Publications de la R&D d'Unicancer

2016

Mutation screening of MIR146A/B and BRCA1/2 3'UTRs in the GENESIS study

Garcia AI et al., Eur J Hum Genet. 2016 Aug;24(9):1324-9.

2015

"Maybe they have found something new" participants' views on returning cohort psychosocial survey results.

Bureau E et al, Health Expect. 2015 Dec;18(6):2425-36. doi: 10.1111/hex.12211. Epub 2014 May 30

2016

Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.

Garcia AI et al., Eur J Hum Genet. 2016 Jan 20. doi: 10.1038/ejhg.2015.284

2015

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.

Bougeard G et al., J Clin Oncol. 2015 Jul 20;33(21):2345-52. doi: 10.1200/JCO.2014.59.5728. Epub 2015 May 26

2015

Familial hematological malignancies: ASXL1 gene investigation.

Hamadou WS et al., Clin Transl Oncol. 2015 Aug 19. [Epub ahead of print]

2015

Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis.

Jenkins MA et al., J Clin Oncol. 2015 Feb 1;33(4):326-31. doi: 10.1200/JCO.2014.55.8536. Epub 2014 Dec 22.

2015

Mutation analysis of PALB2 gene in French breast cancer families.

Damiola F et al., Breast Cancer Res Treat. 2015 Dec;154(3):463-71. doi: 10.1007/s10549-015-3625-7. Epub 2015 Nov 12.

2015

Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2.

Blein S et al., PLoS One. 2015 Sep 25;10(9):e0136192. doi: 10.1371/journal.pone.0136192. eCollection 2015

2015

Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation.

Benusiglio PR, et al., J Med Genet. 2015 Aug;52(8):563-5. doi: 10.1136/jmedgenet-2015-103153. Epub 2015 May 29